Being the most widely used and clinically studied LVAD in the world, the HeartMate II offers proven reliability and safety in more than 16,000 patients worldwide with implants for more than 8 years. Extensive clinical experience with HeartMate II shows the best results and guidelines for  bridge of transplant (PTT) and target therapy (TD).